Susan G Komen for the Cure, a breast cancer organisation, has awarded $2m to researchers in Maryland, US.
As part of the $2m fund, the charity has granted $450,000 to a team led by Lisa Gallicchio at Mercy Medical Center to study why African American breast cancer patients may be more likely to develop heart problems after being treated with aromatase inhibitors.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Another Mercy researcher, Kathy Helzlsouer, will receive almost $600,000 to develop a web-based program to remind breast cancer patients about upcoming treatments and to better manage their symptoms.
At Johns Hopkins, Christopher Umbricht has been given a $600,000 grant to find better ways to identify patients who are most likely to respond to chemotherapy as they fight triple negative breast cancer.
Another $180,000 grant to Gregg Semenza and Daniele Gilkes will be used to study whether dense breast tissue is a cause or a consequence of breast cancer, and whether and how breast density contributes to cancer’s spread.
Komen president Elizabeth Thompson said that the grants may help uncover better treatments, and ensure that breast cancer patients are meaningfully followed during their treatment.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData"The grants tie squarely to our mission to fund cutting-edge breast cancer research along the entire cancer continuum, from prevention to early diagnostics, disparities in outcomes, more effective treatments, and answers for aggressive and metastatic disease," Thompson said.
